Bayesian Capital Management, LP Nevro Corp Transaction History

Bayesian Capital Management, LP

  • $838 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$36.43 - $49.4 $327,359 - $443,908
8,986 New
8,986 $355,000
Q2 2020

Aug 14, 2020
SELL
$89.45 - $129.85 $1.19 Million - $1.72 Million
-13,267 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$70.23 - $144.31 $121,216 - $249,079
1,726 Added 14.96%
13,267 $1.33 Million
Q4 2019

Feb 14, 2020
BUY
$76.41 - $117.54 $881,847 - $1.36 Million
11,541 New
11,541 $1.36 Million

Others Institutions Holding NVRO

# of Institutions
151
Shares Held
39.3M
Call Options Held
67.9K
Put Options Held
1.59M
View Full List

About NEVRO CORP

NVRO Quotes by TradingView
  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email